Advisory Board February 5, 2025

On Monday, FDA granted two biotechnology companies approval for clinical trials that will transplant genetically modified pig organs into patients with kidney failure — an experimental method that could potentially change the lives of thousands of Americans waiting for a limited number of human organs.

5 key tactics to attract and retain transplant patients

The growing field of xenotransplantation

Currently, there are over 106,000 people on the national list for organ transplants in the United States, with many of them looking for kidney transplants. However, there is a significant shortage of available organs. In 2023, only 27,000 kidney transplants were performed.

In recent years, scientists have been working to advance the field of xenotransplantation, or the transplanting of an...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Clinical Trials, FDA, Govt Agencies, Provider, Trends
Novartis Nabs First FDA Nod in Rare Kidney Disease, But Apellis Pharma Is on Its Heels
Scientist Whose Work Led FDA to Ban Food Dye Says Agency Overstated Risk
Who’s Leading the FDA’s AI Race? Top Medical Specialties and Companies to Watch
FDA Funding Changes Could Impact Biotech M&A
FDA issues flu vaccine recommendations: 5 respiratory updates

Share This Article